RecruitingNCT07543328
Light-based brain stimulation for physical symptoms of treatment-resistant depression
About this title
Read the official source — NCT07543328Device studyAges 18–65Taiwan
Understand this study
Who could participate?
This study is for people with depression. Listed age limits: 18 years to 65 years. Other eligibility criteria apply.
- Listed locations
- TaipeiSee all locations and recruitment
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: January 6, 2026
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 40
- Sponsor
- Taipei Veterans General Hospital, Taiwan
- Sponsor type
- Hospital / academic medical center
- Study type
- Device
- Intervention type
- Device
- Locations
- Taiwan
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT07543328
- Official title
Show the full official title
The Clinical Efficacy of Prefrontal Transcranial Photobiomodulation (tPBM) in Patients With Treatment-Resistant Major Depressive Disorder: A Subgroup Analysis Focusing on Somatic Symptoms
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Taipei
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Taipei Veterans General Hospital, Taiwan, a hospital or academic medical center.
Who can participate?
This study is for people with depression. Listed age limits: 18 years to 65 years. Other eligibility criteria apply.
Is this study still recruiting?
The registry lists this study as recruiting.
